483 Novartis Pharmaceuticals Apr 2017

483 Novartis Pharmaceuticals Apr 2017

Joan Johnson FDA, Randa Melhem FDA, Ashley Burns FDA$119.00 - Available Now

FDA investigators audited the Novartis Pharmaceuticals - Morris Plains, NJ, United States facility and issued inspectional observations (via FDA 483) on 07 Apr 2017.

Product details

  • Category: Biologics
  • Inspection end: 07 Apr 2017
  • Location: Morris Plains, United States
  • FEI: 3010353512
Add To Cart